iTonic Holdings Ltd cash flow statement ITOC
In fiscal 2025, which ended Dec 31, 2025, iTonic Holdings Ltd used $3.2 million of cash from operations, down 317.0% from the year before. It spent $3,806 on capital expenditures. Free cash flow was negative, at -$3.2 million. The company returned $8,907 in dividends to shareholders.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
|---|---|---|
| Operating | ||
| Stock-based compensation |
3
|
—
|
| Operating cash flow |
-3
-317.0%
|
-1
|
| Investing | ||
| Capital expenditures |
0
+342.0%
|
0
|
| Investing cash flow |
-1
-156944.0%
|
-0
|
| Financing | ||
| Dividends paid |
0
-97.8%
|
—
|
| Financing cash flow |
-0
-101.4%
|
7
|
| Change in cash | ||
| Effect of exchange rate |
0
+237.2%
|
-0
|
| Net change in cash |
-5
-178.7%
|
6
|
| Free cash flow |
-3
-317.0%
|
-1
|
| Per share | ||
| Free cash flow per share |
-0.20
-230.8%
|
-0.06
|
| Shareholder returns | ||
| Returned to shareholders |
0
|
—
|
| Ratios | ||
| Free cash flow margin |
-618.55%
|
-173.11%
|
| Capital expenditures to revenue |
0.73%
|
0.19%
|
| Stock-based compensation to revenue |
563.16%
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- ITOC (Nasdaq)
- Headquarters
- Beijing
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1970544
- Former names
- Pheton Holdings Ltd (until Jan 13, 2026)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.